Development of a Dose Regimen for Obeticholic Acid in Patients with Primary Biliary Cholangitis and Hepatic Impairment

被引：0
|
作者：
Edwards, Jeffrey [1 ]
LaCerte, Carl [1 ]
Peyret, Thomas [2 ]
Gosselin, Nathalie H. [2 ]
Marier, J. F. [2 ]
机构：
[1] Intercept Pharmaceut Inc, San Diego, CA USA
[2] Pharsight, Princeton, NJ USA
来源：
HEPATOLOGY | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
296
引用
收藏
页码：167A / 167A
页数：1
相关论文
共 50 条
  • [41] Obeticholic Acid in Patients with primary biliary Cholangitis - Clinical Results in 2 Kaerntner Centers
    Bota, Simona
    Hucke, Florian
    Thoma, Bernd
    Flatscher, Kerstin
    Peck-Radosavljevic, Markus
    WIENER KLINISCHE WOCHENSCHRIFT, 2018, 130 : 261 - 261
  • [42] New developments in the treatment of primary biliary cholangitis - role of obeticholic acid
    Jhaveri, Manan A.
    Kowdley, Kris V.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 1053 - 1060
  • [43] Real world effectiveness of Obeticholic Acid in the treatment of Primary Biliary Cholangitis
    Ayyagari, Asha
    Ankoma-Sey, Victor
    Egwim, Chukwuma I.
    Vaquerano, Laura B.
    Pham, Julie
    Nazario, Hector E.
    Doan, Elena I.
    Proffitt, Melanie
    Gonzalez, Stevan A.
    Modi, Apurva A.
    HEPATOLOGY, 2017, 66 : 202A - 202A
  • [44] A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
    Nevens, F.
    Andreone, P.
    Mazzella, G.
    Strasser, S. I.
    Bowlus, C.
    Invernizzi, P.
    Drenth, J. P. H.
    Pockros, P. J.
    Regula, J.
    Beuers, U.
    Trauner, M.
    Jones, D. E.
    Floreani, A.
    Hohenester, S.
    Luketic, V.
    Shiffman, M.
    van Erpecum, K. J.
    Vargas, V.
    Vincent, C.
    Hirschfield, G. M.
    Shah, H.
    Hansen, B.
    Lindor, K. D.
    Marschall, H-U
    Kowdley, K. V.
    Hooshmand-Rad, R.
    Marmon, T.
    Sheeron, S.
    Pencek, R.
    MacConell, L.
    Pruzanski, M.
    Shapiro, D.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (07): : 631 - 643
  • [45] The Efficacy and Safety of Obeticholic Acid (OCA) in Primary Biliary Cholangitis (PBC)
    Al-Khazraji, Ahmed
    Patel, Shyam
    Pradhan, Faruq
    Gordon, Fredric
    Afdhal, Nezam
    Bonder, Alan
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S544 - S544
  • [46] RESULTS OF THE HEROES STUDY: TREATMENT EFFICACY OF OBETICHOLIC ACID ON HEPATIC REAL-WORLD OUTCOMES IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS
    Brookhart, Alan
    Coombs, Charles
    Breskin, Alexander
    Mayne, Tracy
    Ness, Erik
    Fried, Michael
    Hansen, Bettina E.
    Perez, Carla Fiorella Murillo
    Hirschfield, Gideon
    HEPATOLOGY, 2022, 76 : S195 - S196
  • [47] The Appropriate Timing and Dose of Obeticholic Acid in Patients With Primary Biliary Cirrhosis Reply
    Hirschfield, Gideon M.
    GASTROENTEROLOGY, 2015, 149 (02) : 508 - 509
  • [48] Time to initiation of the second-line therapy obeticholic acid in patients with primary biliary cholangitis
    Kumar, Sonal
    MacEwan, Joanna P.
    Levine, Alina
    Bessonova, Leona
    Nair, Radhika
    Wheeler, Darren
    Li, Jing
    Brown, Robert S., Jr.
    JOURNAL OF HEPATOLOGY, 2024, 80 : S314 - S315
  • [49] Obeticholic acid for the treatment of primary biliary cholangitis in adult patients: clinical utility and patient selection
    Bowlus, Christopher L.
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2016, 8 : 89 - 95
  • [50] Effect of obeticholic acid treatment in patients with primary biliary cholangitis on categorical shifts in GLOBE score
    Harms, M. H.
    Lammers, W. J.
    Hansen, B. E.
    Mayo, M.
    Pares, A.
    Malecha, E. S.
    Pencek, R.
    MacConell, L.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S106 - S106
12345